BioMarin Pharma (BMRN) Misses Q4 EPS Views
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $67.13 -0.34%
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Weighted average common shares outstanding, diluted: 167.71M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of $0.39, $0.60 worse than the analyst estimate of $0.99. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $224.38 million.
GUIDANCE:
BioMarin Pharma sees FY2016 revenue of $1.05-1.10 billion, versus the consensus of $1.15 billion.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
